Qitan Technology is a Developer of a genome sequencing technology.
Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 23, 2022 | Series C | ¥700M | 1 | Meituan | — | Detail |
Jun 8, 2021 | Series B | ¥400M | 1 | — | — | Detail |
May 13, 2020 | Series A | ¥100M | 1 | — | — | Detail |
Aug 8, 2019 | Series Unknown | ¥40M | 1 | Yahui Precision Medicine Fund | — | Detail |
Apr 1, 2017 | Series A | ¥3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Meituan | Yes | Series C |
Gaorong Capital | — | Series B |
Yahui Precision Medicine Fund | — | Series A |
Tsinghua Technology Transfer Fund | — | Series A |